Recerca > Nutrició, Metabolisme i Estrès Cel·lular

Fisiopatologia metabòlica

Nombre de publicacions
383
Cercador de publicacions
  • Yin, XY; Willinger, CM; Keefe, J; Liu, J; Fernandez-Ortiz, A; Ibáñez B; Peñalvo J; Adourian, A; Chen, G; Corella, D; Pamplona, R; Portero-Otin, M; Jove, M; Courchesne, P; van Duijn, CM; Fuster, V; Ordovas, JM; Demirkan, A; Larson, MG; Levy, D

    Lipidomic profiling identifies signatures of metabolic risk.

    EBioMedicine 51 102520-102520. .

    [doi:10.1016/j.ebiom.2019.10.046]

  • Prieto, I; Alarcon, CR; Garcia-Gomez, R; Berdun, R; Urgel, T; Portero, M; Pamplona, R; Martinez-Ruiz, A; Ruiz-Sanz, JI; Ruiz-Larrea, MB; Jove, M; Cerdan, S; Monsalve, M

    Metabolic adaptations in spontaneously immortalized PGC-1a knock-out mouse embryonic fibroblasts increase their oncogenic potential.

    Redox Biology 29 101396-101396. .

    [doi:10.1016/j.redox.2019.101396]

  • Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

    Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project

    Diabetes & metabolism 45 595-598. .

    [doi:10.1016/j.diabet.2018.04.002]

  • Gubina, N; Naudi, A; Stefanatos, R; Jove, M; Scialo, F; Fernandez-Ayala, DJ; Rantapero, T; Yurkevych, I; Portero-Otin, M; Nykter, M; Lushchak, O; Navas, P; Pamplona, R; Sanz, A

    Essential Physiological Differences Characterize Short- and Long-Lived Strains of Drosophila melanogaster

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 74 1835-1843. .

    [doi:10.1093/gerona/gly143]

  • Cassanye, A; Martin-Gari, M; Portero-Otin, M; Serrano, JCE

    Adipose Tissue Mitochondrial Factors Profile after Dietary Bioactive Compound Weight Reduction Treatments in a Mice Obesity Model

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 -. .

    [doi:10.3390/ijms20235870]

  • Pamplona, R; Borras, C; Jove, M; Pradas, I; Ferrer, I; Viña J

    Redox lipidomics to better understand brain aging and function

    FREE RADICAL BIOLOGY AND MEDICINE 144 310-321. .

    [doi:10.1016/j.freeradbiomed.2019.03.016]

  • Sánchez E; Betriu À; López-Cano C; Hernández M; Fernández E; Purroy F; Bermúdez-López M; Farràs-Sallés C; Barril S; Pamplona R; Rius F; Hernández C; Simó R; Lecube A

    Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology 18 154-154. .

    [doi:10.1186/s12933-019-0962-6]

  • Pradas, I; Jove, M; Cabre, R; Ayala, V; Mota-Martorell, N; Pamplona, R

    Effects of Aging and Methionine Restriction on Rat Kidney Metabolome

    Metabolites 9 -. .

    [doi:10.3390/metabo9110280]

  • Pradas, I; Rovira-Llopis, S; Naudi, A; Bañuls C; Rocha, M; Hernandez-Mijares, A; Pamplona, R; Victor, VM; Jove, M

    Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women

    SCIENTIFIC REPORTS 9 16033-16033. .

    [doi:10.1038/s41598-019-52263-w]

  • Hernandez-Garcia, D; Granado-Serrano, AB; Martin-Gari, M; Naudi, A; Serrano, JCE

    Efficacy of Panax ginseng supplementation on blood lipid profile. A meta-analysis and systematic review of clinical randomized trials

    Journal Of Ethnopharmacology 243 112090-112090. .

    [doi:10.1016/j.jep.2019.112090]

  • Bahhir, D; Yalgin, C; Ots, L; Järvinen S; George, J; Naudi, A; Krama, T; Krams, I; Tamm, M; Andjelkovic, A; Dufour, E; González de Cózar JM; Gerards, M; Parhiala, M; Pamplona, R; Jacobs, HT; Jõers P

    Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms

    Plos Genetics 15 -. .

    [doi:10.1371/journal.pgen.1008410]

  • Casasnovas, C; Ruiz, M; Schlüter A; Naud?, A; Fourcade, S; Veciana, M; Casta?er, S; Albert?, A; Bargall?, N; Johnson, M; Raymond, GV; Fatemi, A; Moser, AB; Villarroya, F; Portero-Ot?n, M; Artuch, R; Pamplona, R; Pujol, A

    Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

    NEUROTHERAPEUTICS 16 1167-1182. .

    [doi:10.1007/s13311-019-00735-2]